Skip to content

Clinical trials

Active, not recruiting Triple Negative Breast Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Active, not recruiting Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20172
20183
20193
20203
20213
20225
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
National Cancer Institute (NCI)3
Gilead Sciences2
Sunnybrook Health Sciences Centre2
AbbVie1
Astellas Pharma Global Development, Inc.1
Bayer1
BicycleTx Limited1
GlaxoSmithKline1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms23
Breast Neoplasms11
Carcinoma, Non-Small-Cell Lung5
Melanoma4
Ovarian Neoplasms4
Carcinoma, Ovarian Epithelial3
Squamous Cell Carcinoma of Head and Neck3
Colorectal Neoplasms2
Esophageal Neoplasms2
Head and Neck Neoplasms2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.